Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

12.5%

1 terminated out of 8 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results80% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (5)
P 3 (1)

Trial Status

Completed4
Recruiting3
Terminated1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (8)

Research Network

Activity Timeline